Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARGAN INC Director's Dealing 2020

Apr 20, 2020

31210_dirs_2020-04-20_42294ef7-404f-4eb7-b722-2a8caff4e594.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARGAN INC (AGX)
CIK: 0000100591
Period of Report: 2020-04-16

Reporting Person: Deily Richard H (Vice President)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-04-16 Stock Option to purchase Common Stock $33.81 A 10000 Acquired 2030-04-16 Common Stock (10000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 750 Direct

Footnotes

F1: On April 16, 2020, the Reporting Person received 10-year options to purchase 10,000 shares of the Issuer's common stock with an exercise price of $33.81per share. The options will vest ratably over three years on each anniversary of the grant date starting from 4/16/2021.

F2: As of the date of this Filing, the total number of options owned by the Reporting Person includes (a) options to purchase a total of 10,000 shares of common stock at the price of $33.85 per share with the date exercisable of 04/13/2017 and expiration date of 04/13/2026; (b) options to acquire 10,000 shares of common stock at a price of $64.25 per share with Date Exercisable of 04/06/2018 and Expiration Date of 04/06/2027; (c) options to acquire 10,000 shares of common stock at a price of $37.60 per share with Date Exercisable of 04/13/2019 and Expiration Date of 04/13/2028; (d) options to acquire 10,000 shares of common stock at a price of $50.30 per share with Date Exercisable of 4/12/2020 and Expiration Date of 4/12/2029 and;

F3: (e) options to acquire 10,000 shares of common stock at a price of $33.81 per share with a Date Exercisable of 4/16/2021 and Expiration Date of 4/16/2030. Options identified in subjects (c), (d) and (e) are subject to the aforementioned three-year ratably vesting schedule.